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Notum produced by Paneth cells attenuates 
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A decline in stem cell function impairs tissue regeneration during 
ageing, but the role of the stem-cell-supporting niche in ageing is 
not well understood. The small intestine is maintained by actively 
cycling intestinal stem cells that are regulated by the Paneth cell 
niche1,2. Here we show that the regenerative potential of human 
and mouse intestinal epithelium diminishes with age owing to 
defects in both stem cells and their niche. The functional decline 
was caused by a decrease in stemness-maintaining Wnt signalling 
due to production of Notum, an extracellular Wnt inhibitor, in 
aged Paneth cells. Mechanistically, high activity of mammalian 
target of rapamycin complex 1 (mTORC1) in aged Paneth cells 
inhibits activity of peroxisome proliferator activated receptor 
α (PPAR-α)3, and lowered PPAR-α activity increased Notum 
expression. Genetic targeting of Notum or Wnt supplementation 
restored function of aged intestinal organoids. Moreover, 
pharmacological inhibition of Notum in mice enhanced the 
regenerative capacity of aged stem cells and promoted recovery from 
chemotherapy-induced damage. Our results reveal a role of the stem 
cell niche in ageing and demonstrate that targeting of Notum can 
promote regeneration of aged tissues.
Tissue turnover and regenerative capacity decrease with ageing in 
many tissue types4–6. The intestinal epithelium is one of the fastest 
renewing tissues in the human body and has previously been reported 
to regenerate without loss of self-renewal in long-term in vitro organoid 
culture7. However, complications in the gastrointestinal system increase 
with age8–10, and intestines of old mice regenerate more slowly after 
radiation-induced damage11, which suggests reduced stem cell activity.
To assess possible ageing-induced changes in the human 
intestinal epithelium, we used the capacity of intestinal-stem-cell 
(ISC)-containing epithelial crypts to form clonogenic organoids7 as 
an in vitro assay of intestinal regenerative potential. We observed a 
significant age-induced reduction in the organoid-forming capacity 
of colonic crypts derived from biopsies from healthy human donors 
(Fig. 1a). As the heterogeneous human colon material does not allow 
downstream analysis of stem-cell-intrinsic and -extrinsic effects, we 
next analysed the effects of age on mouse small-intestinal epithelium. 
Crypts from old (more than 24-month-old) mice formed significantly 
fewer organoids than those isolated from young (3-to-9-month-old) 
mice (Extended Data Fig. 1a). Notably, regenerative growth of de novo 
crypts was also diminished in the organoids formed by the old crypts 
(Fig. 1b, Extended Data Fig. 1b, c), which indicates a reduction in stem 
cell function. Furthermore, the reduced crypt formation observed 
during serial passage of secondary crypt domains demonstrated that 
the decline in epithelial regeneration was due to alterations intrinsic to 
the epithelium (Extended Data Fig. 1d, e).
Intestinal tissue renewal is largely maintained by the LGR5-
expressing ISCs, which are located between Paneth cells at the crypt 
base. ISCs divide regularly and produce transit-amplifying progenitor 
cells that divide several additional times and gradually differentiate. 
Paneth cells produce antimicrobial peptides and multiple signalling 
factors, such as epidermal growth factor (EGF), Wnt3, Delta-like 
ligands and cyclic ADP ribose (cADPR)2,12, which regulate stemness 
and function of the neighbouring ISCs. To more specifically address 
the separate roles of stem cells and their niche in age-associated intes-
tinal decline, we used Lgr5-eGFP-IRES-creERT2 reporter mice1, which 
enable identification and isolation of Paneth cells, Lgr5–eGFPhi ISCs, 
and transit-amplifying cells that can be further divided into immediate 
eGFPmed and late eGFPlo progenitors.
The aged mouse crypts did not present gross histological altera-
tions, and the fraction of ISCs and transit-amplifying cells that were 5- 
ethynyl-2′-deoxyuridine (EdU) + or Ki67+ was unchanged in old mouse 
and human samples (Extended Data Fig. 1f–h). However, flow cytome-
try of crypts from old mice revealed a significant drop in frequency of 
Lgr5hi ISCs (Fig. 1c), whereas Paneth cell frequency was significantly 
increased in old mice and humans (Fig. 1c, Extended Data Fig. 1i, j). 
As the Lgr5-eGFP-IRES-creERT2 mouse model exhibits mosaic expres-
sion of the eGFP-containing construct1, the alterations in cellular 
frequencies were also validated by immunohistochemical analyses 
of olfactomedin 4 and lysozyme as markers of ISCs and Paneth cells, 
respectively (Extended Data Fig. 1k). The reduction in ISC number, 
together with the unchanged EdU+ frequency suggested that old crypts 
may have a lower output of cells, which possibly contributes to villus 
blunting and slower intestinal turnover during ageing13. As Paneth 
cells positively regulate the number and function of Lgr5hi stem cells 
in young mice2,12, the decoupling of the Lgr5hi:Paneth cell ratio in old 
mice (Extended Data Fig. 1l) raised the possibility that interactions 
between these two cell types change during ageing. To address this, we 
investigated the organoid-forming capacity of co-cultured Lgr5hi and 
Paneth cells isolated from young and old mice (Fig. 1d). Old Paneth 
and Lgr5hi cells both showed cell-type-specific age-induced effects, and 
initiated organoids with reduced efficiency. Consistent with previous 
work, neither cell type formed organoids efficiently by themselves2,12 
but, when co-cultured with Paneth cells, Lgr5hi cells from young mice 
formed organoids at a higher rate than old Lgr5hi cells. Of note, the 
age-induced stem cell defect was partially rescued by co-culture with 
young Paneth cells, whereas old Paneth cells did not fully support 
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organoid formation by young Lgr5hi cells. These data indicate that both 
stem-cell-intrinsic and -extrinsic epithelial factors reduce the regener-
ative potential during intestinal ageing.
Decline in fatty acid oxidation was recently shown to intrinsically 
reduce the function of aged intestinal stem cells14. Old Paneth cells 
extrinsically decreased clonogenic growth of young Lgr5hi cells even 
in a long-term co-culture (Extended Data Fig. 1m, n). While the 
original Paneth cells lasted at least 14 days in such co-cultures 
(Extended Data Fig. 1o), new Paneth cells were continuously pro-
duced by the stem cells, which suggests that exposure to old Paneth cells 
had long-term effects on ISCs and their progeny. To understand the 
mechanics of how age-induced changes in niche–stem cell commu-
nication may influence stem cells, we performed RNA sequencing on 
both cell types (Supplementary Table 1). Old Paneth cells showed spe-
cific deregulation of genes that encode secreted or plasma-membrane- 
associated proteins (Extended Data Fig. 2a, b). Among the key stem-
ness-regulating factors, we noted no alterations in expression of Wnt3 
or Egf, whereas expression of cADPR-producing Bst1 was reduced 
(Extended Data Fig. 2c). However, targeting of Bst1 did not mimic 
the effects of ageing on ad libitum feeding (Extended Data Fig. 2d, e).
As the aged mouse intestine has also recently been reported to 
contain reduced Wnt activity13, we next focused on the extracellular 
Wnt inhibitor Notum, which was significantly upregulated in old 
Paneth cells (Fig. 2a, Extended Data Fig. 2c). Notum is a secreted Wnt 
deacylase that disengages Wnt ligands from Lrp5, Lrp6 and Frizzled 
receptors and reduces Wnt activity locally during development15,16. 
In the intestine, Wnts are produced by the mesenchymal cells lining 
the crypt17,18 and by Paneth cells2,19. Wnt ligands produced by the 
niche adhere to ISC plasma membrane and form a reservoir of stem-
ness-maintaining factors until they become diluted owing to divisions 
outside the Wnt-producing niche20. Of note, the increase in Notum 
expression was strictly restricted to old Paneth cells (Fig. 2b), in which 
its secretion could counter the stemness-maintaining function of Wnt 
ligands. Correspondingly, expression of Wnt-responsive genes was 
reduced in old Lgr5hi cells (Fig. 2c, Extended Data Fig. 2f). Similarly, 
in the human intestine, NOTUM expression was restricted to Paneth 
cells, and its expression correlated with age, whereas LGR5 expression 
and age showed an inverse correlation (Extended Data Fig. 2g, h).
To test whether Notum indeed affects stemness, we cultured isolated 
Lgr5hi cells in the absence of Paneth cells and exogenous Wnt ligands. 
Under these conditions, single Lgr5hi cells form clonal spheroids, 
whereas more-differentiated cells do not (Fig. 2d). When cells from 
young mice were treated with biologically active recombinant Notum 
immediately after isolation to inactivate the membrane-bound Wnts 
that they were exposed to in vivo, their colony-forming efficacy and 
the size of formed spheroids were markedly reduced (Fig. 2d, Extended 
Data Fig. 3a, b). By contrast, colony formation by untreated cells from 
old mice was already reduced and Notum treatment did not have 
further effects. Correspondingly, exogenous Wnt ligands increased 
organoid-forming capacity and long-term regenerative growth 
specifically in the old crypts (Extended Data Fig. 3c, d). However, 
exogenously administered Notum had no effect on isolated crypts with 
tightly connected Paneth and stem cells (Extended Data Fig. 3e–g), 
which suggests that recombinant Notum could not access the Wnt lig-
ands produced by the Paneth cells. Demonstrating the role of epithelial 
Wnt secretion, inhibition of Porcupine20 reduced clonogenic growth 
and the Lgr5hi:Paneth cell ratio of young organoids similarly to ageing 
(Extended Data Fig. 3h–j). In sum, these data highlight the conse-
quences of reduced Wnt activity, and suggested that Notum expressed 
by Paneth cells could represent a mechanism for reducing Wnt activity 
in the old intestinal epithelium.
Notum is regulated by the canonical Wnt pathway, forming a 
negative-feedback loop16. However, unlike in Lgr5hi ISCs, expression of 
Wnt-responsive genes was not significantly altered in old Paneth cells 
(Supplementary Table 1). To find other candidate pathways that regu-
late Notum in Paneth cells, we performed gene set enrichment analysis 
(GSEA) and found that transcripts associated with activity of mTORC1 
were significantly increased in old Paneth cells (Extended Data Fig. 4a). 
mTOR signalling is linked with ageing3, and in the intestine, mTORC1 
modulates ISC activity via the Paneth cell niche in response to calo-
rie intake12. We detected higher levels of phosphorylation of riboso-
mal protein S6 (pS6), a downstream effector of mTORC1, in Paneth 
cells of old mice (Fig. 2e, Extended Data Fig. 4b–d); this increase in 
pS6 phosphorylation was also reflected in whole-crypt preparations 
(Extended Data Fig. 4e). However, the frequencies of pS6+ Paneth 
cells (Extended Data Fig. 4c) or pS6+ crypts (data not shown) were 
not changed, supporting an increase in mTORC1 activity at the level 
of single Paneth cells. By contrast, pS6 levels in ISCs were unchanged 
(Extended Data Fig. 4f, g) but—as reported for the liver3—the age- 
induced mTORC1 activity in Paneth cells was associated with increased 
body mass (Extended Data Fig. 4h), potentially contributing to 
increased mTORC1 activity in old Paneth cells.
Inhibition of mTORC1 with rapamycin or by caloric restriction 
extends lifespan by inducing multisystemic effects21–23. When old 
crypts were transiently treated with rapamycin, regenerative function 
was restored (Extended Data Fig. 5a, b). Moreover, two-week-long 
in vivo treatment of old mice with rapamycin resulted in a marked 
rejuvenation of intestinal regenerative capacity that was attributable 
to effects on both Paneth cells and ISCs (Extended Data Fig. 5c–h). 
However, in contrast to caloric restriction12, systemic rapamycin 
treatment induced broad changes in expression of intestinal Wnt 
ligands, including the stromally produced Wnt4, which regulates 
Notum expression in the developing ovary24 (Extended Data Fig. 5i). 
Correspondingly, Notum expression was increased in crypts from 
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Fig. 1 | Age-associated reduction in intestinal regeneration is caused 
by decreased function of Lgr5+ stem cells and the Paneth cell niche. 
a, Organoid-forming capacity of human colonic crypts (n = 24). Solid 
and dotted lines show linear regression and 95% confidence interval. 
Inset, crypts from donors of more than 60 years of age show significantly 
lower organoid-forming capacity. b, Regenerative growth of crypts from 
young (Y) and old (O) mice. Organoids derived from young mice (n = 6) 
generate more de novo crypt domains (arrowheads) in primary cultures 
(5–9 days after isolation). Representative images from day seven of culture. 
Scale bar, 50 μm. Student’s paired t-test. c, Cellular frequencies analysed by 
flow cytometry (n = 30 young, n = 26 old). For fluorescence-activated cell 
sorting (FACS) gating strategy, see Supplementary Fig. 1. d, Clonogenicity 
of young and old Lgr5hi stem cells co-cultured with young and old Paneth 
cells. n, number of mice analysed. P values shown for comparison of 
average for young Lgr5hi cells co-cultured with young Paneth cells. Young 
mice aged between 3 and 9 months; old mice over 24 months of age in all 
experiments. Unless otherwise mentioned, in box plots, the line represents 
median, the box shows interquartile range and whiskers show the range. 
All other data are represented as mean ± s.d. and conditions compared 
by two-tailed unpaired Student’s t-test. P values shown in corresponding 
panels. P <0.05 is considered significant.
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rapamycin-treated mice (Extended Data Fig. 5j), possibly also reflect-
ing an increase in the number of Paneth cells induced by rapamycin12. 
To address the role of mTORC1 activity in the intestinal epithelium 
in vivo without the rapamycin-induced systemic and stromal effects, 
we activated mTORC1 specifically in the intestinal epithelium of 
mice by Villin–Cre-mediated deletion of tuberculosis sclerosis com-
plex 1 (Tsc1). Tsc1 deletion induced mTORC1 activation and Notum 
expression in Paneth cells, and reduced organoid-forming capacity 
(Extended Data Fig. 5k–m). In sum, these results indicate that increased 
cell-autonomous mTORC1 activity in Paneth cells contributes to the 
regenerative decline of the old intestinal epithelium.
As mTORC1 does not directly regulate transcription, we searched 
for factors that mediate Notum expression downstream of mTORC1 
activation. To that end, GSEA analysis of old Paneth cells also 
indicated a significant reduction in expression of genes that are reg-
ulated by PPAR-α and PPAR-δ (Extended Data Fig. 6a). mTORC1 
activity inhibits PPAR-α3, and we identified a putative binding site for 
PPAR-α in the Notum gene (Extended Data Fig. 6b). To test whether 
downregulation of PPAR-α may contribute to the observed ageing 
phenotypes, we treated young organoid cultures with the PPAR-α 
antagonist GW6471. GW6471 increased expression of Notum, reduced 
regenerative growth and decreased the Lgr5hi:Paneth cell ratio (Fig. 2f, 
g, Extended Data Fig. 6c). Moreover, the ageing-mimicking effects of 
GW6471 were abrogated by Wnt supplementation (Fig. 2g, Extended 
Data Fig. 6d). These data indicate that age-associated change in the 
mTOR–PPAR-α axis modifies Notum expression and the intestinal 
regenerative capacity in a Wnt-dependent fashion.
Finally, to investigate whether endogenous Notum expression 
is functionally relevant for the regenerative function, we targeted 
Notum in organoids to knock out gene function (Extended Data 
Fig. 7a). Notum-knockout organoids showed increased regenera-
tive capacity in vitro and higher growth rate when orthotopically 
transplanted to recipient mouse submucosa (Fig. 3a, Extended 
Data Fig. 7b, c). Moreover, regenerative function of old organoids 
improved significantly after Notum deletion (Fig. 3b, Extended 
Data Fig. 7d). Conversely, activation of endogenous Notum expres-
sion by CRISPR activation decreased Wnt signalling and colony- 
forming capacity of CD24medSSClo cells containing the ISCs of the 
targeted organoids (Extended Data Fig. 7e–g). Finally, to test whether 
the regenerative capacity of old intestines can be increased via the 
intestinal stem cell niche, we used ABC9925, a small-molecule inhib-
itor of Notum. ABC99 blunted the effects of exogenous Notum 
and increased the frequency of Lgr5hi cells in vitro (Extended Data 
Fig. 8a, b), and in vivo treatment of mice by intraperitoneal injection 
with 10 mg per kg (body weight) ABC99 had no noticeable adverse 
effects (Extended Data Fig. 8c). Of note, the Lgr5hi cells that were iso-
lated from old mice after seven days of in vivo treatment with ABC99 
demonstrated colony-forming capacity comparable to cells from 
untreated young mice (Fig. 3c). Moreover, stem-cell-supporting func-
tion of Paneth cells was also restored, which suggests autocrine regu-
lation (Extended Data Fig. 8d). To address whether Notum modulates 
Wnt activity of ISCs in vivo, we next compared the nuclear β-catenin 
levels of ISCs between Paneth cells to those of more-differentiated 
transit-amplifying cells that are not in contact with Notum-producing 
Paneth cells (Extended Data Fig. 8e). As expected, untreated old ISCs 
had reduced nuclear β-catenin levels (Fig. 3d). ABC99 increased 
the nuclear β-catenin levels of ISCs specifically in old mice (Fig. 3d, 
Extended Data Fig. 8f). This increased Wnt activity in old stem cells 
was reflected in increased proliferation, specifically in Olfm4+ stem 
and progenitor cells, in comparison to more differentiated transit- 
amplifying cells (Fig. 3e). To formally test whether Notum inhibition 
promotes regeneration of old intestine, we analysed how advance 
Notum inhibition affects recovery from 5-fluorouracil (5-FU) chemo-
therapy-induced mucositis26,27 that results in loss of body weight owing 
to compromised water retention and nutrient intake27. We treated mice 
with 100 mg per kg (body weight) 5-FU, as the weight of young mice 
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Fig. 2 | Increased Notum expression from Paneth cells attenuates Wnt 
signals in old stem cells. a, Relative Notum mRNA expression from 
isolated Paneth cells (n = 4 old, n = 3 young mice). b, In situ analysis and 
quantification of Notum mRNA expression in mouse jejunum (n = 5 mice 
per age group). Data are mean ± s.d. Scale bar, 10 μm. c, Expression of 
Wnt-responsive genes in isolated old Lgr5hi stem cells relative to young 
stem cells. Number of mice analysed is shown. d, Clonogenic capacity of 
isolated Lgr5+ cells from young and old mice cultured with or without 
1 μg ml−1 recombinant Notum (n = 3 mice per age group). Representative 
images from day seven of culture. Data are mean ± s.d. Scale bar, 100 μm. 
e, Immunoblot and quantification of lysates from isolated young and old 
Paneth cells (n = 3 mice per age group). Tub, tubulin. Data are mean ± s.d. 
f, Relative Notum mRNA expression in small-intestinal organoids of 
young mice treated for 48 h with 5 μM of the PPAR-α inhibitor GW6471 
(n = 4 biologically independent samples). g, Regenerative growth of 
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recovered fully within 5 days of this dose, but old mice did not recover 
(Extended Data Fig. 9a). When Notum activity was inhibited with 
ABC99 for eight days before 5-FU treatment, weight loss in old mice 
was significantly reduced (Fig. 3f, Extended Data Fig. 9b). Moreover, 
the density of differentiated cells in the villi was restored to a level 
similar to that in the young mice, indicating increased regeneration by 
old stem cells (Fig. 3g). These data demonstrate that Notum produced 
by Paneth cells attenuates the regenerative capacity of aged intestinal 
epithelium in vivo by reducing Wnt activity specifically in stem cells.
Appropriate Wnt levels are crucial for many stem cell compartments 
and alterations are seen in multiple pathologies28. Stromal Wnt signals 
have previously been shown to maintain the epithelial stem cell pool 
in the absence of Paneth cells under normal tissue homeostasis17,18,29. 
However, recent studies underline the importance of epithelial Wnt 
signalling in regeneration following injury30. Here we find that, during 
ageing, increased Notum expression in Paneth cells of the ISC niche 
in mouse and human inhibits Wnt signalling and reduces stem cell 
maintenance and regeneration. Simultaneously, reversing observed 
changes in mTORC1–PPAR-α signalling restored epithelial regenera-
tion. Our findings underscore the importance of niche-regulated Wnt 
signals in promoting stemness and demonstrate a link between ageing- 
associated metabolic changes and tissue maintenance. Such effects 
could be missed by studies that demonstrate unaltered clonal dynamics 
of crypts during ageing31. Because Wnt–β-catenin signalling can modu-
late fatty acid oxidation32, increasing Wnt activity in old stem cells could 
also help to restore the age-induced decline in fatty acid oxidation14. 
However, further studies are required to address whether the mecha-
nisms described here also affect tumour risk in the old intestine33. In 
any case, niche–stem cell interactions could provide safer strategies to 
target tissue renewal and age-related decline than strategies directly tar-
geting stem cells. Activation of PPAR-α or PPAR-δ signalling is not an 
attractive option in this regard, as PPAR-δ was recently demonstrated 
to confer tumour-initiating capacity to non-stem cells in the intestine34. 
Notum inhibition with selective inhibitors, such as the ABC99 used 
here, may represent a safer way to treat gastrointestinal complications 
and reduce harmful side-effects of chemotherapeutic agents that pose 
a particular challenge for older individuals35.
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Fig. 3 | Inhibiting Notum activity in vivo restores Wnt-mediated Paneth 
and stem cell function. a, Growth of CRISPR-targeted organoids after 
orthotopic transplantation. Notum-knockout (KO) organoids were co-
transplanted with competing scramble-targeted controls (Scr). (n = 8 mice 
transplanted). Scale bar, 1 mm. WT, wild type. b, Regenerative growth 
of CRISPR-targeted small-intestinal organoids from young and old mice 
(n = 4 mice per group). Student’s paired t-test. c, Clonogenic growth of 
Lgr5hi stem cells from ABC99-treated mice. Control mice received an 
equal amount of the inactive analogue ABC101 (yellow circles) or vehicle 
(number of analysed mice shown). d, Quantification of relative nuclear 
β-catenin intensity of crypt base columnar cells (number of analysed mice 
shown). e, Quantification of EdU+ cellular frequencies within the crypt, 
indicating Olfm4+ cells (number of analysed mice shown). f, Average 
weight change after 5-FU treatment for five days (number of analysed 
mice shown). g, Left, representative images of haematoxylin and eosin 
(H&E) staining of villi after 5-FU treatment for five days. Scale bar, 10 μm. 
Right, quantification of cellular density in ileal villi (cells per micrometre; 
number of analysed mice shown). h, Schematic of the model for stem cell 
maintenance by Paneth cells in the aged niche. Bold weighting of arrows, 
lines and text indicates a higher strength of the biological signal. In these 
experiments, old mice were more than 21 months old. Other than in box 
plots, data are mean ± s.d.; two-tailed unpaired Student’s t-test; P values 
shown in corresponding panels. P <0.05 is considered significant.
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Methods
Isolation of mouse small-intestinal crypts. Mouse small-intestinal crypts were 
isolated as previously described12. In brief, mouse small intestines were flushed 
with cold PBS and opened, and mucus was removed. The intestine was cut into 
small fragments and incubated with several changes of 10 mM EDTA in PBS on 
ice for 2 h. Epithelium was detached by vigorous shaking. To enrich crypts, tissue 
suspension was filtered through 70-μm nylon mesh. Enriched crypts were washed 
once with cold PBS and plated into 60% Matrigel (BD Biosciences) with ENR 
medium. Y-27632 (10 μM) was added to the medium for the first two days.
Isolation of human colonic crypts. Crypts from human colonic biopsies were 
isolated by vigorous shaking after 1-h incubation in ice cold PBS with 10 mM 
EDTA. To enrich crypts, tissue suspension was filtered through 70-μm nylon mesh. 
Enriched crypts were washed once with cold PBS and plated into 60% Matrigel 
(BD Biosciences) and cultured as previously described36.
Organoid culture. Crypts were plated (50–200 crypts per 20 μl drop of 60% 
Matrigel) and overlaid with ENR medium (Advanced DMEM/F12 (Gibco), 
1× Glutamax (Gibco), 100 U/ml penicillin and streptomycin, 10 mM Hepes, 
1× B-27 (Gibco), 1× N-2 (Gibco), 50 ng/ml of mouse EGF (RnD), 100 ng/ml 
noggin (Peprotech), 500 ng/ml of R-spondin-1 (RnD), 1 μM N-acetyl-l-cysteine 
(Sigma-Aldrich)). Y-27632 (10 μM) was added for the first two days of culture. 
Organoid starting frequency was counted after two days of culture unless otherwise 
stated in the figure legend. Primary organoids were cultured for five-to-nine days, 
after which regenerative growth (number of de novo crypt domains per organoid) 
was quantified and organoids were subcultured. Subculturing was performed by 
mechanically disrupting organoids to single-crypt fragments, which were replated 
(1:3) with fresh Matrigel. Secondary cultures were confirmed to start from 
single crypt domains by inspection, and their survival and de novo crypt num-
ber were quantified two days after replating. When indicated, ENR medium was 
supplemented with rapamycin (CST), GW6417 (Tocris), CHIR99021 (BioVision), 
IWP-237 (Sigma) or Wnt3A (RnD). Equal amounts of vehicle (ethanol or DMSO) 
was used in controls. ENR supplemented with 10 nM gastrin (Sigma-Aldrich), 
100 ng/ml Wnt3A (RnD), 10 mM nicotinamide (Sigma-Aldrich), 500 nM A-83-
01 (Sigma-Aldrich) and 10 μM SB202190 (Sigma-Aldrich) was used for isolated 
human colonic crypts36. Colonic organoid starting frequency was counted on day 
seven.
Single-cell sorting and analysis. To isolate single cells, isolated crypts or grown 
organoids were dissociated in TrypLE Express (Gibco) with 1,000 U/ml of DnaseI 
(Roche) at 32 °C (90 s for crypts, 5 min at 37 °C for cultured organoids). Cells were 
washed and stained with the following antibodies: CD31–PE (Biolegend, Mec13.3), 
CD45–PE (eBioscience, 30-F11), Ter119–PE (Biolegend, Ter119), EpCAM–APC 
(eBioscience, G8.8) and CD24–Pacific Blue (Biolegend, M1/69), all at 1:500. 
Finally, cells were resuspended in SMEM medium (Sigma) supplemented with 
7-AAD (Life) (2 μg/ml) for live-cell separation. Cells were sorted using a FACSAria 
II or FACSAria Fusion (BD Biosciences). Sorting strategies: intestinal stem cells, 
Lgr5–eGFPhiEpcam+CD24med(or −)CD31−Ter119 −CD45−7-AAD−; Paneth 
cells, CD24hiSideScatterhiLgr5–eGFP−Epcam+CD31−Ter119−CD45−7-AAD−; 
enteroendocrine cel ls ,  CD24hiSideScatter loLgr5–eGFP−Epcam+ 
CD31−Ter119−CD45−7-AAD−. When analysing organoids, eGFP gates were 
applied directly on the Epcam+CD31−Ter119−CD45−7-AAD− population. 
Equal numbers of Lgr5hi and Paneth cells were co-cultured with ENR medium 
supplemented with additional 500 μg/ml of R-spondin-1 (to yield a final concen-
tration of 1 μg/ml), 100 ng/ml Wnt3A and 10 μM of Jagged-1 peptide (Anaspec) 
for the first six days. Y-27632 (10 μM) was added to the medium for the first 
four days. Single-cell starting frequency and clonogenic growth of primary orga-
noids were analysed at days 5–9. Long-term organoid-forming capacity was 
quantified from twice-subcultured organoids 21 days after isolation. Culture of 
isolated Lgr5hi or CD24medSidescatterlo cells without Paneth cells and Wnt ligands 
was performed in ENR supplemented with 10 μM Chir99021, 10 μM Y-27632 
and 1 μg/ml recombinant human Notum (RnD) and/or 50–500 nM ABC9925 
when indicated for the first 5 days followed by culture in regular ENR medium. 
Colony-forming capacity was quantified on day 5 or day 7 as indicated in the figure 
legends. Cross-sectional area of colonies was quantified from bright-field images 
taken with an inverted cell culture microscope (Nikon TS100 Eclipse, DS-Qi1Mc 
camera) on day 7. Paneth cells from mT/mG mouse-derived organoids were 
isolated as CD24hiSideScatterhiTomato+Epcam+7-AAD− and co-cultured with 
freshly isolated Lgr5hi stem cells. Cell population analysis was performed with 
FlowJo software.
CRISPR–Cas9 gene editing of intestinal organoids. Guide RNAs for the 
target-gene knockout38 were designed with the CRISPR design tool (http://crispr.
mit.edu). Guides were cloned into lentiCRISPR v2 vector. Lentiviral vectors 
were produced in 293fT cells (ThermoFisher, R70007) and concentrated with 
Lenti-X concentrator (Clontech). The 293fT cell line was not authenticated in 
the laboratory, but tested negative for mycoplasma. Cultured intestinal organoids 
were exposed to 1 mM nicotinamide for 2 days before they were processed for 
transduction. Organoids were mechanically disrupted and dissociated to small 
fragments with TrypLE Express supplemented with 1,000 U/ml DnaseI for 5 min 
at 32 °C. Fragments were washed once with SMEM medium and resuspended 
to transduction medium (ENR medium supplemented with 8 μg/ml polybrene 
(Sigma-Aldrich), 1 mM of nicotinamide, 10 μM Y-27632) and mixed with con-
centrated virus. Samples were spinoculated 1 h at 600g 32 °C followed by 2–4 h 
incubation at 37 °C, after which they were collected and plated on 60% Matrigel 
overlaid with transduction medium without polybrene. Two to three days after 
transduction, infected clones were selected by adding 2 μg/ml of puromycin 
(Sigma-Aldrich) to the medium. Four days after selection, clones that survived 
were expanded in normal ENR medium and clonogenic growth was assessed. 
Knockout was confirmed by three-primer PCR around the gRNA-target site. 
In experiments comparing young and old gene-edited organoids, organoids were 
for a maximum of seven days before transduction. LentiCRISPR v2 was a gift from 
F. Zhang (Addgene plasmid 52961)39.
Oligonucleotides used for generation of gRNAs: Notum (1), CACCGGGCGGGG 
CTGCCGTCATTGC, AAACGCAATGACGGCAGCCCCGCCC; Notum (2), CA 
CCGTCGGCGGTGGTTACTCTTTC, AAACGAAAGAGTAACCACCGCCGAC; 
Bst-1, CACCGTTCTGGGGGCAAGAGCGCGG, AAACCCGCGCTCTTGCCC 
CCAGAAC; Scramble (1), CACCGCTAAAACTGCGGATACAATC, AAACGAT 
TGTATCCGCAGTTTTAGC; Scramble (2), CACCGAAAACTGCGGATACAA 
TCAG, AAACCTGATTGTATCCGCAGTTTTC. Oligonucleotides used 
for confirming gene-editing: Notum (1), TATGGCGCAAGTCAAGAGCC, 
CACGTCGGTGACCTGCAATG, CAAGCCAGGTTGACGGCCT; Notum 
(2), CGGTTTGGGGATGAGGGTAG, GTCGGCGGTGGTTACTCTTT, 
GCCAGTCTTTGGAGCTCAT; Bst-1, CCACGGGCTAGAGGAATCAA, 
GCAAGAGCGCGGTGGAC, CTCAGCAGCGTGGTGTACT.
CRISPR–Cas9 gene activation of intestinal organoids. Lenti-SAM-Cre 
vector40 was constructed by assembling five DNA fragments with overlapping ends 
using Gibson Assembly. In brief, fragments containing sequences correspond-
ing to U6-sgRNA-MS2 (PCR amplified from lenti-sgRNA(MS2)-zeo, Addgene 
plasmid 61427), the PGK promoter, MS2-p65-HSF1-T2A (PCR amplified from 
lenti-MS2-P65-HSF1-Hygro, Addgene plasmid 61426), and T2A-Cre were assem-
bled by Gibson assembly into a lentiviral backbone following the manufacturer’s 
guidelines. For short guide RNA (sgRNA) cloning, the Lenti-SAM-Cre vector 
was digested with BsmBI and ligated with BsmBI-compatible annealed oligo-
nucleotides. sgRNAs were designed using the Cas9 activator tool (http://sam.
genome-engineering.org). At least five nucleotides were removed from the 5′ end 
of candidate sgRNAs to enable use of the SAM system with nuclease-active Cas941. 
If the first nucleotide in the truncated sgRNA sequence was not a G, an additional 
nucleotide was removed and replaced with a G to enable efficient expression of 
the sgRNA from the U6 promoter. Sequence against tdTomato was used as a con-
trol42. LSL-Cas9-eGFP mouse-derived small-intestinal organoids were infected 
with Lenti-SAM-Cre-derived virus. Cells with successfully integrated constructs 
were selected by sorting GFP+ cells from organoid cultures. Organoids were grown 
in ENR containing 3 μM CHIR99021 to avoid selection against Notum expression. 
Activation of Notum expression was confirmed by quantitative PCR with reverse 
transcription (RT–qPCR) analysis from whole organoids cultured for two days in 
ENR without CHIR99021. For assessing the effect of endogenous Notum on stem 
cells, CD24medSidescatterlo cells were sorted from organoids cultured for 4–5 days 
in ENR without CHIR99021.
sgRNA sequences used for generating Lenti-SAM-Cre vectors: Notum (dANo-
tum), GCTGGCCGCGGAGAA; tdTomato (dATom), CGAGTTCGAGATCGA.
RT–qPCR. RNA from crypts, single cells and cultured organoids was 
isolated by Trizol purification according to the manufacturer’s instructions (Life 
Technologies) using glycogen as co-precipitant (Life Technologies). Full tissue 
samples were shredded with ceramic beads (Precellys) in RLT buffer and RNA 
was isolated by RNAeasy+ kit (Qiagen) according to the manufacturer’s instruc-
tions. Isolated RNA was transcribed with cDNA synthesis kit using OligodT 
primers (Molecular probes). qPCR amplification was detected by the SYBRGreen 
(2× SYBRGreen mix, Applied Biosciences) method. Samples were run as tripli-
cates and genes of interest were normalized to Gapdh or Actb. Primers used for 
qPCR: Actb, CCTCTATGCCAACACAGTGC, CCTGCTTGCTGATCCACATC; 
Gapdh, ATGGTGAAGGTCGGTGTGAA, TGGAAGATGGTGATGGGCTT; 
Notum, CTGCGTGGTACACTCAAGGA, CCGTCCAATAGCTCCGTATG; 
Bst1, ACCCCATTCCTAGGGACAAG, GCCTCCAATCTGTCTTCCAG; 
Cd44, GCACTGTGACTCATGGATCC, TTCTGGAATCTGAGGTCTCC; Myc, 
CAAATCCTGTACCTCGTCCGATTC, CTTCTTGCTCTTCTTCAGAGTCGC; 
Ascl2, CTACTCGTCGGAGGAAAG, ACTAGACAGCATGGGTAAG; Lgr5, 
ACCCGCCAGTCTCCTACATC, GCATCTAGGCGCAGGGATTG; Axin2, 
AGTGCAAACTCTCACCCACC, TCGCTGGATAACTCGCTGTC; Wnt2b, 
CGTGTAGACACGTCCTGGTG, GTAGCGTTGACACAACTGCC; Wnt3, 
TGGAACTGTACCACCATAGATGAC, ACACCAGCCGAGGCGATG; Wnt4, 
GTACCTGGCCAAGCTGTCAT, CTTGTCACTGCAAAGGCCAC; Wnt5a, 
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ATGAAGCAGGCCGTAGGAC, CTTCTCCTTGAGGGCATCG; Rnf43, CACCAT 
AGCAGACCGGATCC, TATAGCCAGGGGTCCACACA; Sox9, GAGCCG 
GATCTGAAGAGGGA, GCTTGACGTGTGGCTTGTTC.
RNA sequencing and data processing. Total RNA from sorted Paneth (four young 
and five old biological replicates) and Lgr5hi (three young and three old biological 
replicates) cells were isolated by Trizol purification. Samples were first treated 
with HL-dsDNase (Articzymes 80200-050) to remove residual DNA. An Ovation 
Universal RNA-Seq System kit was used for Illumina library preparations (NuGEN 
Technologies). Purified total RNA (100 ng) was used and primers for ribosomal 
removal were designed and used as outlined in the kit manual. Libraries were 
purified with AMPure XP beads (Beckman Coulter), quantified and run on a 
NextSeq 500 sequencer using 75b single-read kits (Illumina). Adaptor sequences 
and low-quality reads were removed from the data using cutadapt43. The data were 
mapped to Mus musculus genome GRCm38.p4 using STAR44. Count data were 
processed using GenomicFeatures and GenomicAlignments45, and the differen-
tial expression analysis was carried out using DESeq246 in R. PreRanked GSEA 
analysis (http://software.broadinstitute.org/gsea/index.jsp) was performed for 
fold-change ranked genes with 1,000 permutations47. Hallmark, Biocarta and Kyoto 
Encyclopedia of Genes and Genomes (KEGG) gene sets are available via GSEA 
Molecular Signatures Database. The ‘PPARd’ gene set was adopted from a previous 
publication48. Gene Ontology enrichment analysis was done for the significantly 
(adjusted P <0.1) altered genes with Gene Ontology Consortium Enrichment 
analysis (http://geneontology.org/page/go-enrichment-analysis), using Fisher’s 
exact test not corrected for multiple testing. Subcellular localization for signifi-
cantly altered genes was taken from the Uniprot database (http://www.uniprot.
org/). Putative transcription factor binding sites for PPAR-α on mouse and human 
NOTUM genes were found by using the DECODE database (SABiosciences) and 
confirmed for mouse using the JASPAR database using PPRE motif (PPARG; 
RXRA) (http://jaspar.genereg.net). RNA sequencing data from human terminal 
ileal samples were obtained from the GTEx Portal at the Human Proteome Atlas 
(https://proteinatlas.org) on 1 June 2018. Sex-matched samples (51 males) were 
divided into three age groups (20–39, 40–59, >60 years old) and proportions 
of expression presented. The data are publicly available through ArrayExpress 
under accession code: E-MTAB-7916 (http://www.ebi.ac.uk/arrayexpress/ 
experiments/E-MTAB-7916).
Immunoblotting. Isolated crypts and cells were lysed in RIPA buffer with 1× 
Halt Protease inhibitor cocktail (ThermoFisher Scientific) and 1× PhosStop 
(Roche) phosphatase inhibitors. Protein concentrations of cleared lysates were 
measured by BCA Protein Kit (ThermoFisher Scientific). For sorted cells equal 
loading was adjusted by sorting the same number of cells. Samples were run on 
4–12% Bis-Tris protein gels (Life Technologies) and blotted on nitrocellulose mem-
branes. Membranes were incubated with primary antibodies: pS6 (Ser240/244, 
CST,5364 for Fig. 2h and Extended Data Figs. 4e, 5d; 1:1,000), pS6 (Ser235/236, 
CST, 4858; 1:500 for Extended Data Fig. 5k), S6 (CST, 2217; 1:500), H3 (CST, 4499; 
1:1,000), β-actin (CST, 4967; 1:2,000), α-tubulin (CST, 2144; 1:1,000) and pS6K 
(ImmunoWay,YP0886; 1:500) at 4 °C overnight, and HRP-conjugated anti-rabbit 
(Sigma-Aldrich; 1:5,000) or anti-mouse (CST; 1:1,000) for 1 h at room temperature. 
Signal was detected using ECL reagent Supersignal West Femto (ThermoFisher 
Scientific). Densitometry was performed with ImageJ, normalizing to β-actin or 
α-tubulin.
Immunohistochemistry and immunofluorescence. Tissues were fixed in 4% 
PFA, paraffin-embedded and sectioned. Antigen retrieval was performed by 
boiling in pH 6 citrate buffer (Sigma-Aldrich) for 5 min. Antibodies: lysozyme 
(DAKO, EC3.2.1.17; 1:750), Ki67 (Abcam, ab15580; 1:300), pS6 (Ser240/244) (CST, 
5364; 1:1,000), Olfm4 (clone PP7, a gift from CST (Extended Data Fig. 1k), CST, 
39141 (Extended Data Fig. 8g); 1:300), β-catenin (BD, 610153; 1:300), E-cadherin 
(BD, 610181; 1:500). Antigen retrieval was followed by permeabilization with 
0.5% Triton-X100 (Sigma) and, in the case of analysis of EdU incorporation, was 
followed by EdU Click-IT chemistry according to manufacturer’s instructions 
(ThermoFisher Scientific). Primary antibodies were detected with biotin-con-
jugated secondary antibodies and DAB substrate on peroxidase-based system 
(Vectastain Elite ABC, Vector Labs). For immunofluorescence, Alexa Fluor 488-, 
Alexa Fluor 594-, Alexa Fluor 633- and Alexa Fluor 647-conjugated anti-rabbit or 
anti-mouse secondary antibodies (Life Technologies, all 1:500) were used. Nuclei 
were co-stained with DAPI (Life Technologies, 1 μg/ml) or Hoechst 33342 (Life 
Technologies, 1 μg/ml).
Immunocytochemistry. Sorted cell populations were treated as previously 
described12. In brief, they were either centrifuged onto charged microscope 
slides with a Shandon Cytospin 4 (ThermoFisher) for 3 min at 800 r.p.m. or 
allowed to settle on poly-l-lysine-coated coverglass-bottomed MatTek dishes 
for 15 min at 37 °C followed by fixation with 4% PFA and immunostaining. 
Antibodies: lysozyme (DAKO, EC3.2.1.17; 1:500), Muc2 (SantaCruz,H-300; 
1:50), counterstains: Hoechst 33342 (Life Technologies, 1 μg/ml), Phalloidin-647 
(Life Technologies; 1:50).
Quantification of nuclear β-catenin localization. Three-micrometre-thick 
confocal sections of β-catenin-stained ileal segments were captured with a 
Leica SP5IIHCS confocal microscope and 63× water-immersion objective and 
12-bit image colour depth. β-catenin mean fluorescence intensity was measured 
by a blinded investigator from three nuclear regions of interest of cells in the 
transit-amplifying zone (cell position +6 and above relative to crypt bottom) fol-
lowed by measurement of intensities in the nuclei of crypt base columnar cells 
(CBCs) and Paneth cells (identified by nuclear morphology and cellular shape). 
Nuclear intensities of CBCs and Paneth cells were always normalized to transit-am-
plifying cells from the same image.
RNA in situ hybridization. RNA in situ hybridization was performed with 
RNAScope 2.5HD Assay–Brown according to the manufacturer’s protocol 
(RNAScope ACDBio). Probes used: mouse Notum: Mm-Notum 428981; mouse 
(positive control) Lgr5: Mm-Lgr5 312178; Human NOTUM: Hs-NOTUM 430311; 
human UBC (positive control): Hs-UBC 310041; Dapb (negative control): Probe-
DapB 310043.
Of note, human NOTUM was only detected from samples freshly fixed in 4% 
PFA followed by paraffin-embedding. Pathological samples fixed in 10% NBF were 
not compatible with this probe.
Statistical analysis. No statistical method was used to calculate the sample size. For 
analysis of in vitro organoid cultures, investigators were blinded when possible, but 
owing to features of co-culture experiments this was not always possible. Blinded 
investigators performed all histological quantification. Microsoft Excel v.16.16.8 
and Graphpad Prism v.8.0.0 were used for statistical analysis and visualization of 
data. All data were analysed by two-tailed Student’s t-test, except RNA sequencing 
data (see ‘RNA sequencing and data processing’), exact P values are presented in 
the corresponding figures. A paired t-test was applied if the day of organoid growth 
quantification varied between pairs (samples processed the same day were paired) 
or phenotype after treatment was compared to the control from the same mouse 
(samples from the same mouse were paired). Whether a test was paired or unpaired 
is noted in the figure legends. P  <0.05 was considered significant.
Human biopsy samples. Human ileal and colon tissue biopsies were obtained 
from 24 healthy subjects who were undergoing a routine colonoscopy. Human 
jejunal samples were obtained from patients undergoing Roux-en-Y gastric bypass 
surgery and fixed in 4% PFA before a routine paraffin-embedding protocol. The 
specimens used for organoid functional assay were stored in normal saline on 
ice until analysis. Exclusion criteria included any history of malignancy, chronic 
liver disease, history suggesting a malabsorption disorder, previous intestinal sur-
gery, renal disease, bleeding disorder that would preclude biopsy, active infection 
or systemic inflammatory disorder. The study regarding relevant samples and 
associated ethical regulations were approved by the institutional review board of 
Massachusetts General Hospital and Helsinki University Hospital. Written and 
informed consent was obtained before enrolment.
Mice. Lgr5-eGFP-IRES-creERT2 mice1 were maintained in a C57BL/6J back-
ground. Rosa26mTmG (JAX 007576), Tsc1fl/fl (ref. 49) (Tsc1tm1Djk/J, JAX 005680), 
Rosa26LSL-ZsGreen (JAX 007906), Rosa26LSL-TdTomato (JAX 007909), Rag2−/− (B6(Cg)-
Rag2tm1.1Cgn/J, JAX 008449) and Rosa26LSL-Cas9-eGFP (JAX 024857) mice were 
obtained from Jackson Laboratories and were on mixed background. Villin-
creERT2 mice were a gift from S. Robine and have previously been described50. 
All animal housing and experiments were done under local institutional regula-
tions. Mice were allocated to experimental groups randomly, but without proper 
randomization. Investigators were not blinded owing to the apparent phenotype 
of aged mice. For in vivo proliferation analysis, 10 mg/kg of EdU (Sigma) in PBS 
was injected intraperitoneally 2 h before mice were euthanized. For in vivo Tsc1 
deletion, Villin-creERT2;Tsc1fl/fl mice were given 5 intraperitoneal injections of 
100 mg/kg tamoxifen (Sigma) on alternate days. Rapamycin treatment was per-
formed as previously described12. ABC99 was produced as previously described25: 
33.3 mg/ml stock solution in ethanol was prepared freshly and further mixed 
1:1:1:17 into Tween-80 (Sigma), PEG-400 (HamiltonResearch) and 0.9% NaCl. 
Mice were injected intraperitoneally with 10 mg/kg ABC99 daily with a last dose 
together with 10 mg/kg EdU 2 h before they were euthanized. Control mice were 
treated with vehicle or an equal amount of the inactive control compound ABC10125. 
5-FU (Sigma) was reconstituted in DMSO at 100 mg/ml and a single intraperitoneal 
injection was given to mice with a dose of 100–200 mg/kg (as described in the figure 
legends). Mice over 24 months of age were considered old, and mice between 3 and 9 
months of age were considered young (denoted ‘O’ and ‘Y’, respectively, throughout 
the figure legends), with the exception of Fig. 3f, g, Extended Data Fig. 9a, b and 
Supplementary Fig. 2, in which old mice were 20–22 months of age. Both sexes were 
used in all experiments. All animal experiments were approved and carried out in 
accordance with the guidelines of the Finnish National Animal Experimentation 
Board and the Committee on Animal Care at MIT.
Organoid transplantation. Notum wild-type and Notum knockout intestinal 
organoids were generated using Notum (2) guide RNAs, as described above, 
in Villin-creERT2;Rosa26LSL-ZsGreen and Villin-creERT2;Rosa26LSL-tdTomato  
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intestinal organoids cultured with 4-OHT to generate zsGreen+ wild-type, 
zsGreen+ knockout, tdTomato+ wild-type and tdTomato+ knockout organoids. 
Organoids were grown in Matrigel and cultured with crypt medium. Before 
transplantation, ZsGreen+ knockout and tdTomato+ wild-type (and, in parallel, 
ZsGreen+ wild-type and tdTomato+ knockout) organoids were chemically dis-
sociated using Cell Recovery Solution (Corning, 354253), and then resuspended 
in a 1:1 ratio in 90% crypt medium and 10% Matrigel at a concentration of 
25 organoids per μl. Organoids were orthotopically transplanted into the colonic 
submucosa of Rag2−/− recipient mice, as previously described51,52. The average 
volume of each injection was 60 μl. Eight weeks later, engrafted organoids were 
assessed using fluorescence colonoscopy followed by fluorescence microscopy using 
GFP and tdTomato filters. Tissues were then fixed in 4% paraformaldehyde for 4–6 h, 
cryopreserved with 30% sucrose in PBS overnight, and then frozen in OCT. Frozen 
tissue sections were stained with DAPI to visualize nuclei, and then imaged for 
tdTomato and GFP. The total number of tdTomato+ and GFP+ cells per mouse 
was then counted using Fiji.
Reporting summary. Further information on research design is available 
in the Nature Research Reporting Summary linked to this paper.
Data availability
RNA sequencing data are publicly available through ArrayExpress with accession 
code E-MTAB-7916. Source Data for Fig. 1–3 and Extended Data Figs. 1–9 are 
available with the online version of the paper. All other data are available from the 
corresponding author upon reasonable request.
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Extended Data Fig. 1 | Characterization of aged intestine. a, Organoid-
forming capacity of crypts from young and old mice (n = 4 mice per group). 
Student’s paired t-test. b, Frequency of organoids unable to form new 
crypts (fission deficiency) in young and old mice (n = 6 mice per group) 
analysed 5–9 days after isolation. Student’s paired t-test. c, Distribution of 
regenerative growth capacity of primary organoids from young and old  
mice (n = 6 mice per group). d, Regenerative growth of subcultured 
secondary mouse organoids (n = 6 mice per group). Student’s paired  
t-test. e, Distribution of regenerative growth capacity of subcultured 
secondary organoids from old and young mice (n = 6 mice per group).  
f, Representative H&E staining of mouse jejunal sections from young and 
old mice (four mice analysed per group). g, Quantification of EdU+ cells in 
jejunal crypts 2 h after administration. Only cells next to lysozyme+ Paneth 
cells were quantified as CBC stem cells. Crypt cells that were not touching 
lysozyme+ cells were quantified as transit-amplifying (TA) cells (n = 5 mice 
per group). Representative image of crypt stained for EdU (cyan), DAPI 
(nuclei, blue), lysozyme (white) and E-cadherin (red). Scale bar, 20 μm. 
h, Quantification of Ki67+ cells in human ileal biopsies. Cells at the crypt 
bottom with elongated nuclei next to postmitotic Paneth cells were counted 
as CBCs. Cells not at the crypt base were considered transit-amplifying cells. 
(n = 6 for 20–25-year-old donors, n = 10 for ≥ 75-year-old donors).  
i, Representative gating of Lgr5hi, Lgr5med, Lgr5lo, Paneth and 
enteroendocrine cells (in relation to Fig. 1c). Quantification of 
enteroendocrine cells (n = 30 young, n = 26 old). For FACS gating strategy, 
see Supplementary Fig. 1. j, Analysis of human ileal biopsy material for 
lysozyme+ Paneth cells (n values for analysed samples shown).  
k, Immunostaining and quantification of Olfm4+ stem and progenitor cells 
(green background, n = 75 crypts from young and old. Five individuals per 
age group) and lysozyme+ Paneth cells in jejunal crypts (red background, 
n = 115 crypts from young and n = 117 crypts from old mice, five 
individuals per age group). Whiskers plotted according to Tukey’s method. 
Scale bars, 10 μm. l, Ratio of Lgr5hi stem cells and Lgr5med progenitor cells 
and ratio of Lgr5hi stem cells and Paneth cells analysed by flow cytometry 
from isolated crypts (n = 30 young, n = 26 old). Whiskers plotted according 
to Tukey’s method. m, Regenerative growth of young Lgr5hi stem cells 
co-cultured with young or old Paneth cells. Quantification at day 8–11 
(n = 6). Representative images are from day 8. Scale bar, 100 μm. Student’s 
paired t-test. n, Long-term clonogenicity of young and old Lgr5hi stem cells 
co-cultured with young and old Paneth cells. Serially passaged organoids 
were quantified 21 days after initial plating (n = 14 mice per age group). 
Combinations compared to average of young Lgr5hi cells co-cultured with 
young and old Paneth cells. o, Fourteen-day co-culture of Paneth cells  
from tdTomato-expressing mouse (R26-mTmG) with Lgr5hi stem cells 
from Lgr5-eGFP-IRES-creERT2 mouse show long-term niche interactions 
in organoid culture. Scale bar, 100 μm. Similar results were seen in three 
replicate wells from co-cultures of the same mice. Y, mice between 3 and 
9 months of age; O, mice over 24 months of age in all experiments. In box 
plots, unless otherwise indicated, the line represents median, the box shows 
interquartile range and whiskers represent the range. All other data are 
mean ±  s.d.; two-tailed unpaired Student’s t-test; exact P values shown in 
corresponding panels.
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Extended Data Fig. 2 | Characterization of gene expression in old 
Paneth and ISCs. a, Venn diagram of gene-expression changes in 
old Paneth cells. (n = 5 mice in old, n = 4 mice in young) b, List of 
Gene Ontology (GO) terms with the highest enrichment among genes 
deregulated in old Paneth cells. Fisher’s exact test, no correction for 
multiple testing. c, Expression of stem-cell-maintaining factors Wnt3 and 
Egf, and of Notum and Bst1 in old Paneth cells (RNA sequencing (RNA-
seq)). Values show fold change in comparison to young Paneth cells. (n = 5 
mice in old, n = 4 mice in young). d, Gene editing of Bst1 confirmed by 
PCR strategy with primers flanking the editing site (191-bp product) 
and hitting the edited site (89-bp product). Representative agarose gel 
image is shown. Experiment repeated once to validate the organoid line 
used in e. e, Regenerative growth of Bst-1 knockout intestinal organoids. 
Organoids were quantified two days after subculturing (n = 5 repeated 
experiments with the same organoid line). f, Venn diagram of gene-
expression changes in old Lgr5hi stem cells. GSEA preranked analysis of 
old versus young Lgr5hi stem cells for the gene list ‘KEGG WNT signalling 
pathway’. Nominal P value is shown (n = 3 mice per age group). g, RNA-
scope for NOTUM mRNA (brown) in human jejunal section. Expression 
seen exclusively in Paneth cells (arrowheads and inset). Experiment 
repeated twice with similar results in independent samples. h, Expression 
of human NOTUM and LGR5 from terminal ileal samples of GTEx 
Consortium (n = 51 sex-matched samples). Expression range is divided 
into three equal-sized tertiles. In box plots, unless otherwise indicated, the 
line represents median, the box shows interquartile range and whiskers 
represent the range. All other data are mean ±  s.d.; two-tailed unpaired 
Student’s t-test; exact P values shown in corresponding panels. For gel 
source data, see Supplementary Fig. 3.
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Extended Data Fig. 3 | Wnt ligands increase regenerative capacity of 
ISCs. a, Distribution of organoid size on day 5 in ENR + 100 ng ml−1 
Wnt3A ± 1μg ml−1 recombinant Notum (n = 50 organoids for Notum-
treated (red), n = 38 organoids for untreated (black)). b, Area of colonies 
from sorted Lgr5hi stem cells from young and old mice (n = 3 mice 
per age group). Area quantified at day 7. c, Organoid-forming capacity 
of crypts from young and old mice treated with 100 ng ml−1 Wnt3A. 
Starting frequency was quantified on day 2 and is represented relative to 
untreated control (n = 10 mice per age group). d, Primary and secondary 
regenerative growth of young and old organoids treated with or without 
100 ng ml−1 Wnt3A for the first 2 days of culture. Primary organoids were 
quantified at day 6 and secondary organoids two days after subculturing. 
Data are represented relative to untreated control (n = 9 mice per age 
group). e, Organoid-forming capacity of isolated crypts from young mice 
treated with or without 1 μg ml−1 recombinant Notum (n = 3 mice).  
f, Primary regenerative growth of organoids from young mice treated with 
or without 1 μg ml−1 recombinant Notum, quantified on day 6 (n = 3 
mice). g, Secondary regenerative growth of organoids from young mice 
treated with or without 1 μg ml−1 recombinant Notum, quantified on day 2 
after subculture (n = 3 mice). h, Organoid-forming capacity of isolated 
crypts at day 2 from young mice treated with Porcupine inhibitor IWP-237 
(n = 3 mice). i, Primary regenerative growth of organoids treated with 
IWP-2 for the first two days of culture. Organoids were quantified on  
day 6 (n = 3 mice). j, Flow cytometry analysis of cellular frequencies 
from Lgr5–eGFP organoids two days after treatment with IWP-2 (n = 4 
mice). Y, mice between 3 and 9 months of age; O, mice over 24 months 
of age in all experiments. In box plots, unless otherwise indicated, the 
line represents median, the box shows interquartile range and whiskers 
represent the range. All other data are mean ±  s.d.; two-tailed unpaired 
Student’s t-test; exact P values shown in corresponding panels.
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Extended Data Fig. 4 | Increased mTORC1 activity in old Paneth cells 
but not in ISCs. a, GSEA analysis for gene list ‘Hallmark mTORC1’  
(for statistics, see ‘RNA sequencing and data processing’ in Methods). 
Nominal P value is shown (n = 5 mice in old, n = 4 mice in young).  
b, Immunohistochemical staining of pS6 (Ser240/244) at mouse jejunal 
crypt. pS6+ Paneth cells at the crypt bottom are separated by pS6− CBCs. 
Scale bar, 25 μm. Experiment was repeated for 14 mice with similar 
results. c, Quantification of pS6+ cells in jejunal crypts (n = 7 mice per age 
group). d, Isolated Paneth cells from young and old mice, stained with pS6 
antibody (red), DAPI (nuclei, blue). Scale bar, 10 μm. Representative image 
from two independent experiments. e, Left, immunofluorescent image of 
isolated crypt stained with pS6 antibody (red), Lgr5–eGFP (green) and 
DAPI (nuclei, blue). Scale bar, 10 μm. Representative of two independent 
experiments. Right, immunoblots of pS6 and pS6K from isolated crypts 
of young and old mice, and densitometric quantification (ratio to actin) 
(n = 14 mice per age group). An outlier (red) deviating >2 s.d. was 
removed from the analysis. f, Isolated Lgr5hi stem cells (eGFP, green) from 
young and old mice, stained with pS6 antibody (red), phalloidin (F-actin, 
white), DAPI (nuclei, blue). Cells were distributed to pS6hi (cells with 
higher than mean pS6 intensity) or pS6lo (lower than mean pS6 intensity) 
categories. n = 3 independent experiments. g, Distribution of pS6 intensity 
in isolated Lgr5hi cells from young and old mice (n = 3 mice per age group, 
number of cells analysed shown above the corresponding box and whisker 
plots). h, Mouse weights (n = 25 for young female, n = 26 for old female, 
n = 20 for young male, n = 19 for old male). Whiskers plotted according 
to Tukey’s method. Y, mice between 3 and 9 months of age; O, mice over  
24 months of age in all experiments. In box plots, unless otherwise 
indicated, the line represents median, the box shows interquartile range 
and whiskers represent the range. All other data are mean ±  s.d.; two-
tailed unpaired Student’s t-test; exact P values shown in corresponding 
panels. For gel source data, see Supplementary Fig. 3.
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Extended Data Fig. 5 | Inhibiting mTORC1 activity in old mice restores 
intestinal regenerative capacity. a, Organoid-forming capacity and 
survival of subcultured intestinal organoids treated with rapamycin. 
Crypts were either treated continuously for four days (2 nM) or with a 
two-day pulse (2 nM pulse, 10 nM pulse) followed by two days in normal 
medium before subculturing and quantification (n = 3). b, Regenerative 
growth of organoids from young and old mice treated with 2 nM 
rapamycin for 2 days ex vivo. Crypt number was scored six to seven days 
after treatment from secondary subcultures (two days after passage) (n = 5 
mice per age group). Student’s paired t-test. Representative images are 
from subcultures on day 2. Scale bar, 100 μm. c, Weight of mice receiving 
daily injections of rapamycin (4 mg kg−1) or vehicle (n = 5 mice per 
group). Daily data points represent median (circles) and interquartile 
range (dashed line). d, Immunoblots of pS6 from isolated crypts of vehicle 
(V)- or rapamycin (R)-treated young and old mice t (n = 4 mice per 
group). e, Organoid-forming capacity of isolated crypts from old mice 
treated with vehicle or rapamycin (n = 4 mice per group). f, Primary 
regenerative growth of organoids from old mice treated with vehicle 
or rapamycin (n = 4 mice per group). g, Organoid-forming capacity of 
young Lgr5hi stem cells co-cultured with Paneth cells isolated from young 
or old mice treated with vehicle or rapamycin (n = 4 mice per group). 
Combinations compared to average of co-cultures with young vehicle- and 
old rapamycin-treated Paneth cells. h, Clonogenic growth of Lgr5hi  
stem cells from young or old mice treated with vehicle or rapamycin 
(n = 4 mice per group); colonies quantified at day 7. i, RT–qPCR analysis 
of relative Wnt2b, Wnt5a, Wnt4, Wnt3 and Lgr5 expression from full 
jejunal samples of old mice treated with rapamycin. Values show fold 
change (expressed in log2) in comparison to old vehicle treated (n values 
of mice analysed shown). Data are mean ± s.e.m. j, RT–qPCR analysis of 
relative Notum and Bst1 expression from crypts of old mice treated with 
rapamycin. Values show fold change (expressed in log2) in comparison to 
old vehicle-treated (n = 3 mice per group). Data are mean ± s.e.m.  
k, Immunoblots of pS6, S6 and H3 from isolated Epcam+ cells of wild type 
(Tsc1WT) and Tsc1 knockout (Tsc1Δ) epithelium (n = 3 mice per group).  
l, Quantification of RNA-scope for Notum mRNA in wild type (Tsc1(WT)) 
and Tsc1 knockout (Tsc1(Δ)) ileal crypts (n = 6 mice for Tsc1(WT) and 
5 mice for Tsc1(Δ)). An outlier (red) deviating >2 s.d was removed from 
the analysis. Representative images of crypts used in quantifications with 
Notum mRNA (brown) in Paneth cells (inset). m, Organoid-forming 
capacity of isolated crypts from Tsc1(WT and Tsc1(Δ) epithelium. 
Quantification was done on day 8. Y, mice between 3 and 9 months of age; 
O, mice over 24 months of age in all experiments. For gel source data, see 
Supplementary Fig. 3.
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Extended Data Fig. 6 | Decreased PPAR activity in aged intestine.  
a, GSEA analysis for ‘Biocarta PPARa’ and ‘PPARd’ gene sets (for statistics, 
see ‘RNA sequencing and data processing’ in Methods). Nominal  
P value is shown (n = 5 mice in old, n = 4 mice in young). b, Schematic 
of the putative PPARα-binding site on the mouse and human NOTUM 
genes found with DECODE. Mouse sequence shown. Bottom, score for the 
discovered site using JASPAR matrix models for mouse PPAR-response 
element (PPRE). PPARG; RXRA motif was used. c, FACS analysis  
of cell populations in primary organoids treated for three days  
with DMSO, CHIR99021 or GW6471 (n = 6 mice for DMSO, n = 5  
mice for CHIR99021 and GW6471). Ratios of Lgr5hi to Paneth cells, and 
Lgr5hi to Lgr5lo cells from the same analysis. Mean CD24 expression of  
live Epcam+ cells are also shown. d, Representative images of mouse 
intestinal organoids treated for 4 days with DMSO, 5 μM GW6471 or  
5 μM GW6471 + 100 ng ml−1 Wnt3A. Arrowheads indicate surviving, 
and red asterisks collapsed, organoids. Scale bar, 100 μm. Experiment was 
repeated four times with similar results. Unless otherwise indicated, data 
are mean ±  s.d.; two-tailed unpaired Student’s t-test; exact P values shown 
in corresponding panels.
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Extended Data Fig. 7 | Notum regulates intestinal stem cell function. 
a, Notum gene targeting. Schematic represents sites of genome editing. 
Gene editing was confirmed by PCR with primers flanking the editing site 
(174 bp product for Notum KO1 and 294 bp product for Notum KO2) and 
hitting the edited site (84 bp product for Notum KO1 and 188 bp product 
for Notum KO2). Representative agarose gel images from two independent 
experiments with similar results are shown. b, Regenerative growth of 
Notum knockout organoids. De novo crypt domains were quantified two 
days after subculture (n = 5 repeated experiments with the same organoid 
lines). Representative images of organoids two days after subculture are 
shown. Scale bar, 100 μm. c, Schematic presenting in vivo competition 
assay of gene-edited organoid growth by orthotopic transplantation to 
immunodeficient Rag2−/− mice. Representative colonoscopy, necroscopy 
and histology images used for assay quantification (n = 8 mice 
transplanted). Scale bars, 1 mm for necroscopy and 200 μm for histology. 
d, Representative images of CRISPR-targeted young and old organoids 
two days after subculturing (n = 4 mice per group). Scale bar, 100 μm. 
e, Relative Notum expression in organoids with synergistic activator 
mediator complex (SAM) targeted to Notum promoter (dA Notum) grown 
for two days in ENR medium. Three independent experiments; relative 
to control (dA Tom). f, Quantification and representative images of day-5 
colonies formed by isolated CD24medSSClo cells from Notum activator 
(dA Notum) and control (dA Tom) organoids. Scale bar, 100 μm. n = 4 
repeated experiments with the same organoid line. g, RT–qPCR analysis 
of relative Axin2 and Lgr5 expression in CD24medSSClo cells sorted 
from Notum activator (dA Notum) organoids. Values show fold change 
(expressed in log2) in comparison to control (dATom) (n = 3 replicate 
wells per organoid line). In box plots, unless otherwise indicated, the 
line represents median, the box shows interquartile range and whiskers 
represent the range. All other data are mean ±  s.e.m.; two-tailed unpaired 
Student’s t-test; exact P values shown in corresponding panels. For gel 
source data see Supplementary Fig. 3.
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Extended Data Fig. 8 | Notum inhibitor ABC99 prevents Wnt 
inactivation. a, Flow cytometry analysis of cell populations in primary 
organoids treated for eight days with 500 nM ABC99 (n = 3 mice)  
relative to DMSO control. Student’s paired t-test. b, Clonogenic growth  
of Lgr5hi stem cells on day 5 treated with or without 50 nM ABC99  
and/or 500 ng ml−1 recombinant Notum (two independent experiments 
with similar results, one experiment with three replicate wells shown). 
c, Relative weight of mice treated with daily injections of ABC99 (10 mg 
per kg (body weight)) or control (vehicle or ABC101 10 mg per kg (body 
weight)) (n = 10 mice for young control and young ABC99, n = 8 mice  
for old control and n = 9 mice for old ABC99). Daily data points  
represent median (circles) and interquartile range (dashed line).  
d, Clonogenic growth of young Lgr5hi stem cells co-cultured with young 
or old Paneth cells from mice treated with ABC99 or control (n values 
for analysed mice shown). Combinations compared to average of co-
cultures with young control (−) and old ABC-treated (+) Paneth cells. 
Control mice received an equal amount of the inactive analogue ABC101 
(yellow circles) or vehicle. e, Representative image of immunofluorescent 
staining of ileal crypts used for quantification of nuclear β-catenin (white) 
intensity. Paneth cells (red arrowheads) and CBCs (green arrowheads) 
were identified by cellular and nuclear (DAPI, blue) morphology. Their 
nuclear β-catenin levels were compared to transit-amplifying cells (white 
arrowheads). Scale bar, 20 μm. Experiment was repeated twice with a total 
of 26 mice all showing strongest nuclear β-catenin at the crypt bottom. 
f, Immunofluorescent staining of histological sections from old ileum. 
β-catenin (white), lysozyme (red) and DAPI (nuclei, blue). Scale bar, 
10 μm. Quantification of relative nuclear β-catenin intensity of Paneth cells 
(red arrowhead) (n values for analysed mice shown). For quantification 
of CBCs (green arrowhead) see Fig. 3d. g, Immunofluorescent staining 
of histological sections from old ileum. Olfm4, green; EdU, red; DAPI 
(nuclei), blue. Scale bar, 20 μm. Quantification of EdU+ cellular 
frequencies within the crypt (n values for analysed mice shown). Y, mice 
between 3 and 9 months of age; O, mice over 24 months of age in all 
experiments. In box plots, unless otherwise indicated, the line represents 
median, the box shows interquartile range and whiskers represent the 
range. All other data are mean ±  s.d.; two-tailed unpaired Student’s  
t-test; exact P values shown in corresponding panels.
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Extended Data Fig. 9 | Old intestine recovers poorly from 5-FU-
induced damage. a, Body weights of young and old mice following single 
injection of 5-FU (100–200 mg kg−1). Two mice per group, body weight 
relative to day of injection (day 0). b, Relative body weight of young and 
old mice treated for one week with or without ABC99 followed by single 
5-FU (100 mg kg−1) injection (n = 8 mice for young vehicle, old vehicle 
and young ABC99-treated, n = 10 mice for old ABC99-treated). Daily data 
points represent median (circles) and interquartile range (dashed line). 
Daily weight of old ABC99-treated mice were compared to old controls 
with two-tailed unpaired Student’s t-test; exact P values shown under the 
corresponding daily weight. Young mice between 3 and 4 months of age; 
old mice over 20 months of age.
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H3, CST, 4499, 1:1000 
beta-Actin, CST, 4967, 1:2000 
alpha-Tubulin, CST, 2144, 1:1000 
pS6K, ImmunoWay, YP0886, 1:500 
Muc 2, Santa Cruz, H-300, 1:50 
anti-rabbit-Alexa-488, ThermoFischer, A11008, 1:500 
anti-rabbit-Alexa-594, ThermoFischer, A11012, 1:500 
anti-mouse-Alexa-647, ThermoFischer, A21203, 1:500 
anti-rabbit-Alexa-633, ThermoFischer, A21071, 1:500 
anti-rabbit-Alexa-647, ThermoFischer, A21244, 1:500  
anti-mouse-Alexa-647, ThermoFischer, A21235, 1:500  
anti-rabbit HRP, Sigma-Aldrich, A0545, 1:5000 
anti-mouse HRP, CST, 7076, 1:1000
Validation Only commercial antibodies were used that were validated by the vendor, data available on the manufacturer's website. For 
immunostainings, replicate samples stained with only secondary antibodies were used to determine specificity of the primary 
antibody. For pS6 (S240/244) antibodies, signal reduction was observed in samples treated with rapamycin, known inhibitor of 
mTORC1 activity both in immunoblots and in immunofluorescence. For pS6 (S235/236) increase in corresponding band intensity 
was observed after deletion of Tsc1, a known inhibitor of mTORC1 activity. For Lysozyme antibody, specific staining was 
observed in phenotypic Paneth cells (large granular cells at the bottom of crypts of the small intestine). Olfm4 antibodies stained 
only cells at the base of crypts but not phenotypic Paneth cells. Ki-67 antibody stained nuclei of epithelial cells that were in 
crypts, and not outside the crypt where proliferative capacity disappears. Ecadherin stained membranes of epithelial cells and 
has been used in the laboratory before with similar results. beta-Catenin antibody stained membranes of all epithelial cells and 
nuclei of cells at the crypt base where high Wnt-activity is known to exist. Muc-2 antibody stains large mucous producing cells 
and a mucus layer on top of the epithelium along the crypt to villus axis in the small and large intestine in histological samples.  
Eukaryotic cell lines
Policy information about cell lines
Cell line source(s) 293fT cells were purchased from Thermo Fischer Scientific,R70007, lot# 1745311
Authentication Cell lines were not authenticated
Mycoplasma contamination Cell lines were regularly tested for mycoplasma contamination. All cell lines tested negative.
Commonly misidentified lines
(See ICLAC register)
No commonly misidentified cell lines were used (ICLAC Version 8.0)
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals Mouse (Mus musculus): 
Wild type and Lgr5-EGFP-IRES-CreERT2 and Rag2(-/-) mice were C57BL/6J background. 
Villin-CreERT2, Tsc1(fl/fl), Rosa26(LSL-ZsGreen), Rosa26(LSL-TdTomato), Rosa26(mT/mG) mice and Rosa26(LSL-Cas9EGFP) mice 
were mixed background. 
In all experiments, animals used were between 3 and 26 months of age. Age groups are stated in corresponding figure legends. 
Both female and male mice were used throughout the study.
Wild animals Study did not involve wild animals
Field-collected samples Study did not involve field-collected samples
Ethics oversight Experiments using laboratory mice were approved and carried out in accordance with the guidelines of the Finnish national 
animal experimentation board and the Committee on Animal Care at MIT
Note that full information on the approval of the study protocol must also be provided in the manuscript.
Human research participants
Policy information about studies involving human research participants
Population characteristics For human colonic and ileal biopsies, patients between 32-81 years old, 12 female and 12 male, for Figure 1a  and patients 
between 21-88 years, gender not know, for Extended Data Fig. 1h,j. undergoing routine colonoscopy.  Exclusion criteria included 
any history of malignancy, chronic liver disease, history suggesting a malabsorption disorder, previous intestinal surgery, renal 
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disease, bleeding disorder that would preclude biopsy, active infection, or systemic inflammatory disorder. Human jejunal 
samples (Extended Data Fig. 2g) were obtained from patients undergoing Roux en-Y gastric bypass surgery.
Recruitment For colonoscopy biopsies, patient were recruited when they were attending routine colonoscopy at the clinic. For Roux-en-Y 
gastric bypass, patients were recruited as a part of a larger study months prior to the surgery. Recruitment unlikely caused bias 
relevant to the current study. Written and informed consent was obtained prior to enrolment.
Ethics oversight The study regarding relevant samples was approved by the institutional review board of Massachusetts General Hospital 
(Boston, Massachusetts) and Helsinki University Hospital.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
Flow Cytometry
Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation Mouse primary intestinal epithelial cells were isolated by EDTA treatment of minced tissue followed by gentle mechanical 
dissociation and enzymatic treatment with TrypLE Express enzyme to yield single cell suspension.
Instrument FACSAriaII and FACSAriaIII Fusion (BD) were used to analyse and collect data.
Software FACSDiva 7 and 8 were used to collect the data. FlowJo v10 was used for analyzing cellular frequencies.
Cell population abundance Lgr5+ stem cell populations were ~99 % pure based on fluorescent microscopy of the post-sort fraction. Paneth cells were ~90% 
pure based on phase contrast microscopy (granulated morphology) and Lysozyme staining of the post-sort fraction. Culture of 
Paneth cells alone was performed in order to analyze the frequency of Paneth-ISC doublets.
Gating strategy Single cells were gated by using FSC-A,FSC-W,SSC-A and SSC-W parameters as detailed in Supplementary data 1. Initially the right 
population was identified by overlaying Lgr5-EGFP on SSC-A vs FSC-A gate. Similar overlay were used to ensure that doublets 
were not included in the downstream gating. For fluorescent markers, positive populations were identified by comparing to 
unstained control sample from the same tissue.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
